Search Results - "Olivier, Christoph B."

P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells by Siegel, Patrick M., Sander, Laura, Fricke, Alba, Stamm, Johannes, Wang, Xiaowei, Sharma, Prerna, Bassler, Nicole, Ying, Ya-Lan, Olivier, Christoph B., Eisenhardt, Steffen U., Bode, Christoph, Ahrens, Ingo, Diehl, Philipp, Peter, Karlheinz

“…P 2 Y 12 blockade improves patient outcomes after myocardial infarction. As well as antithrombotic effects, anti-inflammatory effects may contribute to this…”
Get full text

D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention by Gjermeni, Diona, Anfang, Viktoria, Szabó, Sofia, Vetter, Hannah, Venhoff, Ana C, Leggewie, Stefan, Hesselbarth, David, Trenk, Dietmar, Buechsel, Martin, Westermann, Dirk, Olivier, Christoph B

“…This study aimed to evaluate the association of antiphospholipid antibodies (aPL) and conventional markers of coagulation with ischemic and bleeding risk in…”
Get full text

Factors associated with lower quarter performance-based balance and strength tests: a cross-sectional analysis from the project baseline health study by Taylor, Kenneth A, Carroll, Megan K, Short, Sarah A, Celestin, Bettia E, Gilbertson, Adam, Olivier, Christoph B, Haddad, Francois, Cauwenberghs, Nicholas

“…Physical performance tests are predictive of mortality and may screen for certain health conditions (e.g., sarcopenia); however, their diagnostic and/or…”
Get full text

Platelet Bone Morphogenetic Protein-4 Mediates Vascular Inflammation and Neointima Formation after Arterial Injury by Jank, Marietta, von Niessen, Nikolaus, Olivier, Christoph B, Schmitt, Hannah, Anto-Michel, Nathaly, Hilgendorf, Ingo, Bode, Christoph, Moser, Martin, Esser, Jennifer S, Zhou, Qian

“…The purpose of this study is to investigate the role of platelet bone morphogenetic proteins (BMP)-4 during vascular inflammation and remodeling in a mouse…”
Get full text

Medical history of coronary artery disease and time to electrocardiogram in the emergency department: a real-life, single-center, retrospective analysis by Heger, Lukas Andreas, Glück, Tina, Kaier, Klaus, Hortmann, Marcus, Rieder, Marina, Siegel, Patrick M, Diehl, Philipp, Wengenmayer, Tobias, Olivier, Christoph B, Bode, Christoph, Busch, Hans-Joerg, Duerschmied, Daniel, Ahrens, Ingo

“…Timely acquisition of 12-lead Electrocardiogram (ECG) in the emergency department (ED) is crucial and recommended by current guidelines. To evaluate the…”
Get full text

The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y12-Dependent Platelet Inhibition Independently of the Platelet Count by Olivier, Christoph B, Meyer, Melanie, Bauer, Hans, Schnabel, Katharina, Weik, Patrick, Zhou, Qian, Bode, Christoph, Moser, Martin, Diehl, Philipp

“…This study aimed to assess the association of clinical factors with P2Y12-dependent platelet inhibition as monitored by the ratio of ADP- to TRAP-induced…”
Get full text

Use and Outcomes of Acute Treatment Strategies in Patients with Severe Aortic Valve Stenosis by Piepenburg, Sven M, Kaier, Klaus, Olivier, Christoph B, Bothe, Wolfgang, Heidt, Timo, Jäckel, Markus, Peikert, Alexander, Wolf, Dennis, Zehender, Manfred, Bode, Christoph, Dürschmied, Daniel, von Zur Mühlen, Constantin, Stachon, Peter

“…This study aimed to evaluate the acute treatment of patients with severe aortic valve stenosis in Germany. Three treatment strategies in 11,027 patients…”
Get full text

Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study by Heger, Lukas Andreas, Danzer, Martin, Bode, Christoph, Hortmann, Marcus, Duerschmied, Daniel, Olivier, Christoph B., Moser, Martin

“…Background: There is limited data evaluating the prescription practices for antithrombotic therapy in patients with atrial fibrillation (AF) following elective…”
Get full text

Why digital health trials can fail: Lessons learned from a randomized trial of health coaching and virtual cardiac rehabilitation by Olivier, Christoph B., Middleton, Stephanie K., Purington, Natasha, Shashidhar, Sumana, Hereford, Jody, Mahaffey, Kenneth W., Turakhia, Mintu P.

“…We performed a trial to evaluate the efficacy of a blended intervention with personalized health coaching and virtual cardiac rehabilitation to improve…”
Get full text

Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury by Rieder, Marina, Laumann, Rosmarie, Witsch, Thilo, Schanze, Nancy, Heger, Lukas, Olivier, Christoph B., von zur Muehlen, Constantin, Bode, Christoph, Ahrens, Ingo, Lother, Achim, Duerschmied, Daniel, Hortmann, Marcus

“…Background: Activated platelets release serotonin during acute myocardial infarction (AMI), aggravating myocardial damage and ischemia/reperfusion (I/R)…”
Get full text

Anticoagulation and anaemia: old opponents from the era of VKA? by Bode, Christoph, Olivier, Christoph B, Duerschmied, Daniel

“…Abstract…”
Get full text

Is Bleeding Always Bad?: Bad Boy Bleeding by Bode, Christoph, Olivier, Christoph B., Duerschmied, Daniel

“…[Display omitted]…”
Get full text

Time from blood draw to multiple electrode aggregometry and association with platelet reactivity by Hesselbarth, David, Gjermeni, Diona, Szabo, Sofia, Siegel, Patrick M., Diehl, Philipp, Moser, Martin, Bode, Christoph, Olivier, Christoph B.

“…Results from multiple electrode aggregometry (MEA) may vary according to pre-analytic factors. This study aimed to analyze the association of time from blood…”
Get full text

TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran by Olivier, Christoph B, Weik, Patrick, Meyer, Melanie, Weber, Susanne, Anto-Michel, Nathaly, Diehl, Philipp, Zhou, Qian, Geisen, Ulrich, Bode, Christoph, Moser, Martin

“…Abstract Background/objectives Novel (or non-vitamin K antagonist) oral anti-coagulants (NOACs) are antagonists of coagulation factors (F) Xa (rivaroxaban) or…”
Get full text

Triple antithrombotic therapy in cardiac patients: more questions than answers by Moser, Martin, Olivier, Christoph B, Bode, Christoph

“…Many cardiac patients require combined antithrombotic therapy consisting of an anticoagulant and inhibition of platelet function. The most frequent indications…”
Get full text

Early platelet dysfunction in patients receiving extracorporeal membrane oxygenation is associated with mortality by Siegel, Patrick Malcolm, Chalupsky, Julia, Olivier, Christoph B., Bojti, István, Pooth, Jan-Steffen, Trummer, Georg, Bode, Christoph, Diehl, Philipp

“…Extracorporeal membrane oxygenation (ECMO) is used for patients with cardiopulmonary failure and is associated with severe bleeding and poor outcome. Platelet…”
Get full text

Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors by Olivier, Christoph B., Weik, Patrick, Meyer, Melanie, Weber, Susanne, Diehl, Philipp, Bode, Christoph, Moser, Martin, Zhou, Qian

“…Dabigatran and rivaroxaban are novel, vitamin K-independent oral anticoagulants (NOACs) and act via antagonism of the coagulation factor (F) IIa (dabigatran)…”
Get full text

Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study by Gjermeni, Diona, Anfang, Viktoria, Vetter, Hannah, Szabó, Sofia, Hesselbarth, David, Gauchel, Nadine, Siegel, Patrick M., Kaier, Klaus, Kille, Alexander, Franke, Kilian, Leggewie, Stefan, Trenk, Dietmar, Duerschmied, Daniel, Bode, Christoph, Westermann, Dirk, Olivier, Christoph B.

“…High on-clopidogrel platelet reactivity (HPR) associates with ischemic risk in patients after percutaneous intervention (PCI). This study aimed to evaluate the…”
Get full text

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation by Gjermeni, Diona, Saglam, Nertila Poci, Olivier, Christoph B, Kühlkamp, Volker

“…In patients undergoing catheter ablation for atrial fibrillation (AF), direct oral anticoagulants (DOACs) are as effective and safe as the vitamin K antagonist…”
Get full text

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial by Barco, Stefano, Voci, Davide, Held, Ulrike, Sebastian, Tim, Bingisser, Roland, Colucci, Giuseppe, Duerschmied, Daniel, Frenk, André, Gerber, Bernhard, Götschi, Andrea, Konstantinides, Stavros V, Mach, François, Robert-Ebadi, Helia, Rosemann, Thomas, Simon, Noemi R, Spechbach, Hervé, Spirk, David, Stortecky, Stefan, Vaisnora, Lukas, Righini, Marc, Kucher, Nils, Roth Zetzsche, Stéphanie, Spescha, Rebecca, Leeger, Claudia, Butscheid, Yulia, Probst, Eliane, Micieli, Evy, Forgo, Gabor, Johner, Fabian, Grigorean, Alexandru, Vatsakis, Georgios, Keller Lang, Dagmar, Rampini Speck, Silvana, Hasse, Barbara, Rueegg, Marco, Arnold, Isabelle, Nickel, Christian, Busch, Jeannette, Blondon, Marc, Glauser, Frédéric, Cittone, Micol G, Kessler, Chiara, Gjermeni, Diona, Olivier, Christoph B, Gauchel, Nadine, Biever, Paul, Hobohm, Lukas, Becker, Dorothea, Schindewolf, Marc, Kuenzi, Arnaud, Ulrich, Silvia

“…BACKGROUNDCOVID-19 is a viral prothrombotic respiratory infection. Heparins exert antithrombotic and anti-inflammatory effects, and might have antiviral…”
Get full text